SEC 13F Intelligence

Hoylecohen, LLC / ABBV

Hoylecohen, LLC’s Abbvie Inc Position

Does Hoylecohen, LLC own Abbvie Inc (ABBV)? Yes66.4K shares worth $11M (+0.86% of its 13F portfolio) as of Q2 2024, down from 69.8K shares the prior filed quarter.

Position Value
$11M
Q2 2024
Shares
66.4K
% of Portfolio
+0.86%
Quarters Held
23
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ3 ’19Q4 ’19: $3MQ1 ’20: $3MQ2 ’20: $4MQ2 ’20Q3 ’20: $4MQ4 ’20: $10MQ1 ’21: $10MQ1 ’21Q2 ’21: $10MQ3 ’21: $10MQ4 ’21: $12MQ4 ’21Q1 ’22: $14MQ2 ’22: $13MQ3 ’22: $12MQ3 ’22Q4 ’22: $12MQ1 ’23: $11MQ2 ’23: $9MQ2 ’23Q3 ’23: $11MQ4 ’23: $11MQ1 ’24: $13MQ1 ’24Q2 ’24: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202466.4K$11M+0.86%
Q1 202469.8K$13M+0.97%
Q4 202372.2K$11M+0.91%
Q3 202371.1K$11M+0.98%
Q2 202370.5K$9M+0.84%
Q1 202371.2K$11M+1.06%
Q4 202272.3K$12M+1.16%
Q3 202285.9K$12M+1.26%
Q2 202287.2K$13M+1.39%
Q1 202287.4K$14M+1.21%
Q4 202188.1K$12M+0.99%
Q3 202188.3K$10M+0.90%
Q2 202188.9K$10M+0.78%
Q1 202189.0K$10M+0.98%
Q4 202088.9K$10M+1.10%
Q3 202040.8K$4M+0.53%
Q2 202040.0K$4M+0.66%
Q1 202038.3K$3M+0.58%
Q4 201936.0K$3M+0.51%
Q3 201937.6K$3M+0.49%
Q2 201937.9K$3M+0.48%
Q1 201941.1K$3M+0.58%
Q4 201845.9K$4M+0.87%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hoylecohen, LLC’s full portfolio or all institutional holders of ABBV.